반응식
[C:1]([C:3]1[CH:8]=[CH:7][C:6]([NH:9][C@H:10]([CH2:14][CH:15]2[CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]2)[C:11]([NH2:13])=[O:12])=[CH:5][C:4]=1[NH:21][C:22]1[S:26][N:25]=[C:24]([CH3:27])[CH:23]=1)#[N:2].C([O-])([O-])=[O:29].[K+].[K+].OO>CS(C)=O>[NH2:13][C:11](=[O:12])[C@H:10]([NH:9][C:6]1[CH:7]=[CH:8][C:3]([C:1]([NH2:2])=[O:29])=[C:4]([NH:21][C:22]2[S:26][N:25]=[C:24]([CH3:27])[CH:23]=2)[CH:5]=1)[CH2:14][CH:15]1[CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of (R)-2-(4-cyano-3-(3-methylisothiazol-5-ylamino)phenylamino)-3-cyclohexylpropanamide (241 mg, 0.629 mmol) in DMSO (2 mL), K2CO3 (300 mg, 2.17 mmol) and H2O2 (50% aq., 1.00 mL) were added. After being stirred at 90 C for 10 min, the mixture was purified by HPLC to give the titled compound (81 mg). MS 402.4 (M+H); UV 204.7, 298.3 nm
후처리
- customthe mixture was purified by HPLC
출처 및 근거
- ORD 기록
- ord-7b7d6cf910fd447aa944416c9292be09
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08846928B2
연결된 노트
불러오는 중…